Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Pharm Biol. 2021 Dec;59(1):1432-1440. doi: 10.1080/13880209.2021.1990357.
Atherosclerosis predisposes individuals to adverse cardiovascular events. L. (Acanthaceae) is a traditional remedy used for diabetes and inflammatory conditions.
To investigate the anti-atherosclerotic activity of a leaf methanol extract (CNME) in a type 2 diabetic (T2D) rat model induced by a high-fat diet (HFD) and low-dose streptozotocin.
Sixty male Sprague-Dawley rats were divided into five groups: non-diabetic fed a standard diet (C), C + CNME (500 mg/kg, orally), diabetic fed an HFD (DM), DM + CNME (500 mg/kg), and DM + Metformin (DM + Met; 300 mg/kg). Treatment with oral CNME and metformin was administered for 4 weeks. Fasting blood glucose (FBG), serum lipid profile, atherogenic index (AI), aortic tissue superoxide dismutase levels (SOD), malondialdehyde (MDA), and tumour necrosis factor-alpha (TNF-α) were measured. The rats' aortas were stained for histological analysis and intima-media thickness (IMT), a marker of subclinical atherosclerosis.
The CNME-treated diabetic rats had reduced serum total cholesterol (43.74%; = 0.0031), triglycerides (80.91%; = 0.0003), low-density lipoprotein cholesterol (56.64%; = 0.0008), AI (51.32%; < 0.0001), MDA (60.74%; = 0.0026), TNF-α (61.78%; = 0.0002), and IMT (39.35%; < 0.0001) compared to untreated diabetic rats. SOD level, however, increased (53.36%; = 0.0326). These CNME effects were comparable to those in the metformin-treated diabetic rats.
possesses anti-atherosclerotic properties, which may be due to reductions in vascular tissue oxidative stress, inflammation, and serum AI. Continued studies on atherosclerotic animal models are suggested.
动脉粥样硬化使个体易发生不良心血管事件。(爵床科)是一种传统的用于治疗糖尿病和炎症的药物。
研究甲醇提取物(CNME)对高脂肪饮食(HFD)和低剂量链脲佐菌素诱导的 2 型糖尿病(T2D)大鼠模型的抗动脉粥样硬化活性。
将 60 只雄性 Sprague-Dawley 大鼠分为五组:非糖尿病喂食标准饮食(C)、C+CNME(500mg/kg,口服)、糖尿病喂食 HFD(DM)、DM+CNME(500mg/kg)和 DM+二甲双胍(DM+Met;300mg/kg)。口服 CNME 和二甲双胍治疗持续 4 周。测量空腹血糖(FBG)、血清脂质谱、致动脉粥样硬化指数(AI)、主动脉组织超氧化物歧化酶水平(SOD)、丙二醛(MDA)和肿瘤坏死因子-α(TNF-α)。对大鼠主动脉进行染色以进行组织学分析和内膜中层厚度(IMT),这是亚临床动脉粥样硬化的标志物。
CNME 治疗的糖尿病大鼠的血清总胆固醇(43.74%; = 0.0031)、甘油三酯(80.91%; = 0.0003)、低密度脂蛋白胆固醇(56.64%; = 0.0008)、AI(51.32%; < 0.0001)、MDA(60.74%; = 0.0026)、TNF-α(61.78%; = 0.0002)和 IMT(39.35%; < 0.0001)均低于未治疗的糖尿病大鼠。然而,SOD 水平增加了(53.36%; = 0.0326)。这些 CNME 作用与二甲双胍治疗的糖尿病大鼠相当。
具有抗动脉粥样硬化特性,这可能是由于血管组织氧化应激、炎症和血清 AI 降低所致。建议对动脉粥样硬化动物模型进行进一步研究。